Join us in

04 Days 05 H 43 Min 30 Sec

Join us in

04 Days 05 H 43 Min 30 Sec

Hyperscale Longevity

Rewriting the Code of Biology and Unlocking Longer, Healthier Lives.
May 5-8

2025

San Jose Convention Center
California, USA

May 5-8

2025

San Jose Convention Center

California, USA

About the event

From cellular reprogramming and senescence-targeting therapies to advanced diagnostics and aging clocks, the field of longevity is accelerating at an unprecedented pace. Scientists and entrepreneurs are pushing the boundaries of what it means to grow old—turning age into a modifiable variable rather than an inevitable decline.

At the intersection of synthetic biology, regenerative medicine, and AI, new tools and interventions are emerging to extend healthspan, delay age-related diseases, and potentially reverse biological aging. Whether through epigenetic reprogramming, engineered immune cells, or next-gen nutraceuticals, the longevity revolution is here.

This is where new paradigms in health, vitality, and human potential are no longer constrained by the limits of time.

Top Sessions

1

May 08
11:40 AM

-

12:10 PM
Unbound Biology: Cracking the Age Code

What if aging were optional? In this provocative session, Bryan Johnson (Founder, Don't Die) and Jason Kelly (Co-Founder & CEO, Ginkgo Bioworks) explore how synthetic biology, data-driven optimization, and radical self-experimentation are converging to rewrite the rules of human longevity. From cellular reprogramming to biological automation, they’ll discuss what it takes to crack the age code—and what the future of ageless living might look like.

[…]

2

May 08
9:40 AM

-

10:05 AM
A Rallying Call to Work on Longevity

In this keynote, Peter Diamandis, will issue a rallying call to redefine how we think about aging and harness the synergy of biotech, AI, and bold thinking to push the boundaries of healthy lifespan extension. He will draw on insights from The Longevity Insider’s Guide to present transformative solutions poised to disrupt the healthcare landscape. He will spotlight how entrepreneurs, researchers, and investors can join forces to accelerate breakthroughs and overcome the most urgent challenges in aging. By shifting from scarcity to possibility, he will show how collective innovation can usher in an era of unprecedented longevity, redefining what it means to thrive at every stage of life.

[…]

3

May 06
4:30 PM

-

5:15 PM
How Breakthroughs in Cellular Reprogramming Could Transform Aging

Epigenetic reprogramming has rapidly become the hottest area in longevity biotech, attracting unprecedented attention and billions in investment in just the last two years. Building on Shinya Yamanaka's Nobel Prize winning iPSC reprogramming, a new wave of biotech startups are now racing to extend the concept to therapeutically rejuvenate the cells in our bodies. This panel brings together the leading researchers and entrepreneurs of this field to explore the science and recent breakthroughs driving the excitement, the challenges of bringing these therapies to market, and the future of a field that could redefine what it means to age.

[…]

4

May 06
1:35 PM

-

2:05 PM
The Neural Frontier: Pioneering Tomorrow's Brain Technologies

The stuff of science fiction is becoming reality! These scientist and entrepreneurs are tackling the next generation of brain connectomics, advanced brain-computer interfaces, neuromodulation, and stem cell replacement. These technologies aim to treat specific disorders today, but will enable a path for us to become cyborgs and live longer.

[…]

5

May 08
11:09 AM

-

11:13 AM
Designing Biology for a Generation That Never Ages

What if aging wasn’t a fate, but a variable we could measure—and reprogram? In this visionary session, Alina Su, Founder & CEO of Generation Lab, reveals how next-gen bioengineering is unlocking the future of longevity. By quantifying organ-specific biological age and intervening via Therapeutic Plasma Exchange (TPE) with next-generation synthetic plasma, (No Blood Boys needed!) Generation Lab is pioneering a new class of aging entropy diagnostic with preventative therapies. Alina shares how we’re moving from reactive medicine to proactive self-optimization—where biology isn’t just observed, but engineered to help us live longer, stronger, and smarter.

[…]

6

May 07
3:30 PM

-

4:15 PM
Next-Gen Medicine: AI-Powered Advances Reshaping Human Therapeutics

Dive into the cutting-edge today, not just the promises of tomorrow. This dynamic breakout session features biotech visionaries actively leveraging machine learning and AI to transform the engineering of human therapeutics. Hear firsthand from industry pioneers pushing the boundaries—from accelerating drug target discovery to streamlining clinical development pipelines. Learn how advanced analytics and big data are already enhancing personalized medicine, boosting clinical success rates, and rapidly reshaping the future landscape of healthcare. Don't miss this inside look at the real-world innovations redefining what's possible in therapeutic discovery and precision medicine.

[…]

7

May 08
2:30 PM

-

3:15 PM
Space Therapies: Accelerating Biotech Solutions for Health Beyond Earth

Space is among the harshest and least hospitable environments for humans. Every human biological system is affected by the space environment. The biological stress has a deleterious impact on health and physical capabilities, and the extreme conditions and isolation take a significant toll on mental performance and behavior. By 2040, hundreds of people will be in space at any given time, and more than 80% of those are predicted to be private citizens; for the reliability, safety, health, and enjoyment of those private participants, new solutions and therapeutics are needed to maintain health and wellbeing.

[…]

8

May 07
4:30 PM

-

5:15 PM
Synthetic Biology Frontiers in Transplantation: Engineering Durable Therapeutic Solutions

This cutting-edge session explores the intersection of synthetic biology, materials science, and transplantation medicine to address key challenges in cell, tissue, and organ transplantation. We'll examine innovative approaches to enhance transplant durability, improve integration with host systems, and advance the field of regenerative medicine. Examples include: genetically engineered cells for enhanced survival, 3d-printed scaffolds and organoids, advances in xenotransplantation, and others.

[…]

9

May 06
4:30 PM

-

5:15 PM
Bio/acc and Biohack: The Science Behind the Hype

Bio/acc and Biohacking have both become popular movements on Twitter of late. This session brings together people who 'hype' them up and people who temper these sectors with science and point out flawed approaches. Get ready for a spicy conversation.

[…]

10

May 07
4:30 PM

-

5:15 PM
The Living Future: How SynBio, Genomics, and Regenerative Medicine are Transforming Human Health

Synthetic biology is blurring the lines between biology and technology, unlocking breakthroughs in regenerative medicine, biofabrication, and personalized healthcare. This panel brings together leading innovators who are shaping the future of human health. Join this session to explore the role of multidisciplinary technologies in healthcare. Understand how genomics, synthetic biology, and regenerative medicine are personalizing treatment and examine the ethical and practical challenges in deploying next-gen biotechnologies.

[…]

1

May 08
11:40 AM

-

12:10 PM
Unbound Biology: Cracking the Age Code

What if aging were optional? In this provocative session, Bryan Johnson (Founder, Don't Die) and Jason Kelly (Co-Founder & CEO, Ginkgo Bioworks) explore how synthetic biology, data-driven optimization, and radical self-experimentation are converging to rewrite the rules of human longevity. From cellular reprogramming to biological automation, they’ll discuss what it takes to crack the age code—and what the future of ageless living might look like.

[…]

2

May 08
9:40 AM

-

10:05 AM
A Rallying Call to Work on Longevity

In this keynote, Peter Diamandis, will issue a rallying call to redefine how we think about aging and harness the synergy of biotech, AI, and bold thinking to push the boundaries of healthy lifespan extension. He will draw on insights from The Longevity Insider’s Guide to present transformative solutions poised to disrupt the healthcare landscape. He will spotlight how entrepreneurs, researchers, and investors can join forces to accelerate breakthroughs and overcome the most urgent challenges in aging. By shifting from scarcity to possibility, he will show how collective innovation can usher in an era of unprecedented longevity, redefining what it means to thrive at every stage of life.

[…]

3

May 06
4:30 PM

-

5:15 PM
How Breakthroughs in Cellular Reprogramming Could Transform Aging

Epigenetic reprogramming has rapidly become the hottest area in longevity biotech, attracting unprecedented attention and billions in investment in just the last two years. Building on Shinya Yamanaka's Nobel Prize winning iPSC reprogramming, a new wave of biotech startups are now racing to extend the concept to therapeutically rejuvenate the cells in our bodies. This panel brings together the leading researchers and entrepreneurs of this field to explore the science and recent breakthroughs driving the excitement, the challenges of bringing these therapies to market, and the future of a field that could redefine what it means to age.

[…]

4

May 06
1:35 PM

-

2:05 PM
The Neural Frontier: Pioneering Tomorrow's Brain Technologies

The stuff of science fiction is becoming reality! These scientist and entrepreneurs are tackling the next generation of brain connectomics, advanced brain-computer interfaces, neuromodulation, and stem cell replacement. These technologies aim to treat specific disorders today, but will enable a path for us to become cyborgs and live longer.

[…]

5

May 08
11:09 AM

-

11:13 AM
Designing Biology for a Generation That Never Ages

What if aging wasn’t a fate, but a variable we could measure—and reprogram? In this visionary session, Alina Su, Founder & CEO of Generation Lab, reveals how next-gen bioengineering is unlocking the future of longevity. By quantifying organ-specific biological age and intervening via Therapeutic Plasma Exchange (TPE) with next-generation synthetic plasma, (No Blood Boys needed!) Generation Lab is pioneering a new class of aging entropy diagnostic with preventative therapies. Alina shares how we’re moving from reactive medicine to proactive self-optimization—where biology isn’t just observed, but engineered to help us live longer, stronger, and smarter.

[…]

6

May 07
3:30 PM

-

4:15 PM
Next-Gen Medicine: AI-Powered Advances Reshaping Human Therapeutics

Dive into the cutting-edge today, not just the promises of tomorrow. This dynamic breakout session features biotech visionaries actively leveraging machine learning and AI to transform the engineering of human therapeutics. Hear firsthand from industry pioneers pushing the boundaries—from accelerating drug target discovery to streamlining clinical development pipelines. Learn how advanced analytics and big data are already enhancing personalized medicine, boosting clinical success rates, and rapidly reshaping the future landscape of healthcare. Don't miss this inside look at the real-world innovations redefining what's possible in therapeutic discovery and precision medicine.

[…]

7

May 08
2:30 PM

-

3:15 PM
Space Therapies: Accelerating Biotech Solutions for Health Beyond Earth

Space is among the harshest and least hospitable environments for humans. Every human biological system is affected by the space environment. The biological stress has a deleterious impact on health and physical capabilities, and the extreme conditions and isolation take a significant toll on mental performance and behavior. By 2040, hundreds of people will be in space at any given time, and more than 80% of those are predicted to be private citizens; for the reliability, safety, health, and enjoyment of those private participants, new solutions and therapeutics are needed to maintain health and wellbeing.

[…]

8

May 07
4:30 PM

-

5:15 PM
Synthetic Biology Frontiers in Transplantation: Engineering Durable Therapeutic Solutions

This cutting-edge session explores the intersection of synthetic biology, materials science, and transplantation medicine to address key challenges in cell, tissue, and organ transplantation. We'll examine innovative approaches to enhance transplant durability, improve integration with host systems, and advance the field of regenerative medicine. Examples include: genetically engineered cells for enhanced survival, 3d-printed scaffolds and organoids, advances in xenotransplantation, and others.

[…]

9

May 06
4:30 PM

-

5:15 PM
Bio/acc and Biohack: The Science Behind the Hype

Bio/acc and Biohacking have both become popular movements on Twitter of late. This session brings together people who 'hype' them up and people who temper these sectors with science and point out flawed approaches. Get ready for a spicy conversation.

[…]

10

May 07
4:30 PM

-

5:15 PM
The Living Future: How SynBio, Genomics, and Regenerative Medicine are Transforming Human Health

Synthetic biology is blurring the lines between biology and technology, unlocking breakthroughs in regenerative medicine, biofabrication, and personalized healthcare. This panel brings together leading innovators who are shaping the future of human health. Join this session to explore the role of multidisciplinary technologies in healthcare. Understand how genomics, synthetic biology, and regenerative medicine are personalizing treatment and examine the ethical and practical challenges in deploying next-gen biotechnologies.

[…]

1

May 08
11:40 AM

-

12:10 PM
Unbound Biology: Cracking the Age Code

What if aging were optional? In this provocative session, Bryan Johnson (Founder, Don't Die) and Jason Kelly (Co-Founder & CEO, Ginkgo Bioworks) explore how synthetic biology, data-driven optimization, and radical self-experimentation are converging to rewrite the rules of human longevity. From cellular reprogramming to biological automation, they’ll discuss what it takes to crack the age code—and what the future of ageless living might look like.

[…]

2

May 08
9:40 AM

-

10:05 AM
A Rallying Call to Work on Longevity

In this keynote, Peter Diamandis, will issue a rallying call to redefine how we think about aging and harness the synergy of biotech, AI, and bold thinking to push the boundaries of healthy lifespan extension. He will draw on insights from The Longevity Insider’s Guide to present transformative solutions poised to disrupt the healthcare landscape. He will spotlight how entrepreneurs, researchers, and investors can join forces to accelerate breakthroughs and overcome the most urgent challenges in aging. By shifting from scarcity to possibility, he will show how collective innovation can usher in an era of unprecedented longevity, redefining what it means to thrive at every stage of life.

[…]

3

May 06
4:30 PM

-

5:15 PM
How Breakthroughs in Cellular Reprogramming Could Transform Aging

Epigenetic reprogramming has rapidly become the hottest area in longevity biotech, attracting unprecedented attention and billions in investment in just the last two years. Building on Shinya Yamanaka's Nobel Prize winning iPSC reprogramming, a new wave of biotech startups are now racing to extend the concept to therapeutically rejuvenate the cells in our bodies. This panel brings together the leading researchers and entrepreneurs of this field to explore the science and recent breakthroughs driving the excitement, the challenges of bringing these therapies to market, and the future of a field that could redefine what it means to age.

[…]

4

May 06
1:35 PM

-

2:05 PM
The Neural Frontier: Pioneering Tomorrow's Brain Technologies

The stuff of science fiction is becoming reality! These scientist and entrepreneurs are tackling the next generation of brain connectomics, advanced brain-computer interfaces, neuromodulation, and stem cell replacement. These technologies aim to treat specific disorders today, but will enable a path for us to become cyborgs and live longer.

[…]

5

May 08
11:09 AM

-

11:13 AM
Designing Biology for a Generation That Never Ages

What if aging wasn’t a fate, but a variable we could measure—and reprogram? In this visionary session, Alina Su, Founder & CEO of Generation Lab, reveals how next-gen bioengineering is unlocking the future of longevity. By quantifying organ-specific biological age and intervening via Therapeutic Plasma Exchange (TPE) with next-generation synthetic plasma, (No Blood Boys needed!) Generation Lab is pioneering a new class of aging entropy diagnostic with preventative therapies. Alina shares how we’re moving from reactive medicine to proactive self-optimization—where biology isn’t just observed, but engineered to help us live longer, stronger, and smarter.

[…]

6

May 07
3:30 PM

-

4:15 PM
Next-Gen Medicine: AI-Powered Advances Reshaping Human Therapeutics

Dive into the cutting-edge today, not just the promises of tomorrow. This dynamic breakout session features biotech visionaries actively leveraging machine learning and AI to transform the engineering of human therapeutics. Hear firsthand from industry pioneers pushing the boundaries—from accelerating drug target discovery to streamlining clinical development pipelines. Learn how advanced analytics and big data are already enhancing personalized medicine, boosting clinical success rates, and rapidly reshaping the future landscape of healthcare. Don't miss this inside look at the real-world innovations redefining what's possible in therapeutic discovery and precision medicine.

[…]

7

May 08
2:30 PM

-

3:15 PM
Space Therapies: Accelerating Biotech Solutions for Health Beyond Earth

Space is among the harshest and least hospitable environments for humans. Every human biological system is affected by the space environment. The biological stress has a deleterious impact on health and physical capabilities, and the extreme conditions and isolation take a significant toll on mental performance and behavior. By 2040, hundreds of people will be in space at any given time, and more than 80% of those are predicted to be private citizens; for the reliability, safety, health, and enjoyment of those private participants, new solutions and therapeutics are needed to maintain health and wellbeing.

[…]

8

May 07
4:30 PM

-

5:15 PM
Synthetic Biology Frontiers in Transplantation: Engineering Durable Therapeutic Solutions

This cutting-edge session explores the intersection of synthetic biology, materials science, and transplantation medicine to address key challenges in cell, tissue, and organ transplantation. We'll examine innovative approaches to enhance transplant durability, improve integration with host systems, and advance the field of regenerative medicine. Examples include: genetically engineered cells for enhanced survival, 3d-printed scaffolds and organoids, advances in xenotransplantation, and others.

[…]

9

May 06
4:30 PM

-

5:15 PM
Bio/acc and Biohack: The Science Behind the Hype

Bio/acc and Biohacking have both become popular movements on Twitter of late. This session brings together people who 'hype' them up and people who temper these sectors with science and point out flawed approaches. Get ready for a spicy conversation.

[…]

10

May 07
4:30 PM

-

5:15 PM
The Living Future: How SynBio, Genomics, and Regenerative Medicine are Transforming Human Health

Synthetic biology is blurring the lines between biology and technology, unlocking breakthroughs in regenerative medicine, biofabrication, and personalized healthcare. This panel brings together leading innovators who are shaping the future of human health. Join this session to explore the role of multidisciplinary technologies in healthcare. Understand how genomics, synthetic biology, and regenerative medicine are personalizing treatment and examine the ethical and practical challenges in deploying next-gen biotechnologies.

[…]

  • It is really a technological cornucopia of new ideas and deployments of technology.

    Chris Mason

    Professor, Cornell University

    It’s been a tremendously exciting conference for me, and very different to what I've been to before. Everyone's been extraordinary and generous with their time and ideas.

    Drew Berry

    Molecular Animator

    Taking the SynBioBeta stage is an unmatched opportunity to share our work with the people who truly comprehend its enormity. It is the ultimate gathering for those at the forefront of the synthetic biology revolution.

    Jodi Barrientos

    CEO, Ribbon Bio

    Every year there's more. There's more companies, there's more technologies, more applications of technologies.

    Julianna LeMieux

    Deputy Editor in Chief, GEN

    This is an amazing conference, and a great chance to see a snapshot of the industry. It's a place where you can make a lot of little molecular interactions and collisions.

    Kate Rubins

    NASA Astronaut

    I first came to SynBioBeta to learn more about the field. I stayed for the community. There is no better place to go learn and network.

    Kristin Ellis

    Partner, Lowercarbon Capital

    An extraordinary and extraordinarily important conference, the only conference where I feel I learn a lot. SynBioBeta is my tribe!

    Martine Rothblatt

    Founder & CEO, United Therapeutics

    A conference where every single person I met was a) brilliant b) had a new fresh tech idea and c) could have a huge positive transformational impact on the world and d) could communicate all this clearly and concisely.

    Mary Lou Jepsen

    Founder, Openwater

    Easily my favorite and most stimulating conference. Every day I was pleasantly surprised by some nugget of insight. Coming from another field I was apprehensive, but the SynBioBeta community had a meaningful impact on me, and made me feel instantly welcome.

    Mickey McManus

    Senior Advisor & Executive Coach, BCG

    I cannot think of a better place where I can find new talent each year to work with our teams.

    Paul Stamets

    Founder & Member, Fungi Perfecti

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025